CG Oncology, Inc. released positive results from cretostimogene study for high-risk BCG-unresponsive bladder cancer patients.

Novartis agreed to buy US biotech Mariana Oncology Inc. to strengthen its pipeline of drugs that can specifically target ...

Following an upsized IPO earlier this year, CG Oncology on Friday posted promising Phase III data for cretostimogene, which ...

The FDA is expected to make decisions about therapies for small-cell lung cancer and myelodysplastic syndrome next month. The US Food and Drug Administration (FDA) is expected to decide in June ...

Q1 2024 Earnings Call Transcript May 4, 2024 Kura Oncology, Inc. isn’t one of the 30 most popular stocks among hedge funds at ...

Lauren orchestrated a heartwarming Christmas reunion for an admitted mother undergoing a stem cell transplant, ensuring she ...

By Adam L. Cataldo American Oncology Network has initiated a hiring search for a new chief financial officer. Dave Gould will step down as CFO effective ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Relay Therapeutics (RLAY – Research ...

Elevation Oncology (ELEV) is gearing up to report EO-3021 phase 1 data to treat patients with advanced solid tumors. Read ...

FORT MYERS, Fla., May 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today ...

With BridgeBio’s attention squarely on seeing acoramidis through regulatory approval, the company is slicing off its oncology unit as a standalone company. Leaders of the existing unit are joining the ...

Alembic Pharmaceuticals Limited received an EIR from the US FDA for its Gujarat oncology facility at Panelav. Inspection was from Feb 28 to Mar 8. Company to reveal Q4, FY 2024 results.